Skip to main content
Clinical Trials/NL-OMON45194
NL-OMON45194
Completed
Not Applicable

Reduction of antibiotic therapy by biomarkers in patients with CAP episodes - REDUCE study

Medisch Centrum Alkmaar0 sites468 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pneumonia
Sponsor
Medisch Centrum Alkmaar
Enrollment
468
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Centrum Alkmaar

Eligibility Criteria

Inclusion Criteria

  • Male and female patients with a diagnosis of CAP and all criteria listed below:
  • 1\. Age 18 or above, no upper age limit will be employed.
  • 2\. Patients must require hospitalisation.
  • 3\. Clinical presentation of an acute illness with one or more of the following symptoms:
  • a. Temperature \* 38\.0 \*C (100\.4°F)
  • b. Dyspnoea
  • c. Cough (with or without expectoration of sputum)
  • d. Chest pain
  • e. Hemoptysis
  • f. Malaise or fatigue

Exclusion Criteria

  • Subjects presenting with any of the following will not be included in the study:
  • 1\. Severe immunosuppression (HIV infection, chemotherapy).
  • 2\. Active neoplastic disease.
  • 3\. Obstruction pneumonia (e.g. from lung cancer).
  • 4\. Aspiration pneumonia.
  • 5\. Pneumonia that developed within 8 days after hospital discharge.
  • 6\. Unable and/or unlikely to comprehend and/or follow the protocol.
  • 7\. Pregnant and/or lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials